M. Peterson

发表

Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk.

Eric O Long, M. Peterson, 2008, Immunity.

NK Cell Proliferation Induced by IL-15 Transpresentation Is Negatively Regulated by Inhibitory Receptors

Eric O Long, O. Antón, Y. Tagaya, 2015, The Journal of Immunology.

The MHC Class II Molecule I-Ag7 Exists in Alternate Conformations That Are Peptide Dependent1

A. Sant, M. Peterson, L. Arneson, 2000, The Journal of Immunology.

Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants

Peter D. Crompton, J. Mascola, I. Wilson, 2021, bioRxiv.

PD-1 Expression on NK Cells in Malaria-Exposed Individuals Is Associated with Diminished Natural Cytotoxicity and Enhanced Antibody-Dependent Cellular Cytotoxicity

Peter D. Crompton, Eric O Long, J. Skinner, 2020, Infection and Immunity.

The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44

Mark S. Anderson, Jim Miller, M. F. Naujokas, 1993, Cell.

Broadly neutralizing antibodies target the coronavirus fusion peptide

Peter D. Crompton, J. Mascola, J. Yewdell, 2022, bioRxiv.

The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM.

A. Sant, M. Peterson, 1998, Journal of immunology.

Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41

Jim Miller, M. Peterson, 1992, Nature.

DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules.

A. Sant, C. Stebbins, M. Peterson, 1996, Journal of immunology.

Zinc-Induced Polymerization of Killer-Cell Ig-like Receptor into Filaments Promotes Its Inhibitory Function at Cytotoxic Immunological Synapses.

Eric O Long, Steven S. Vogel, Santosh Kumar, 2016, Molecular cell.

Natural Killer Cells and Mast Cells from gp49B Null Mutant Mice Are Functional

Eric O Long, D. Dombrowicz, C. Stebbins, 2000, Molecular and Cellular Biology.

Potent effects of low levels of MHC class II-associated invariant chain on CD4+ T cell development.

D. Lo, Jim Miller, M. F. Naujokas, 1995, Immunity.

The adaptor protein Crk controls activation and inhibition of natural killer cells.

Eric O Long, Dongfang Liu, M. Peterson, 2012, Immunity.

Homogenous expression of killer cell immunoglobulin-like receptors (KIR) on polyclonal natural killer cells detected by a monoclonal antibody to KIR2D.

Eric O Long, C. Watzl, M. Peterson, 2000, Tissue antigens.

Canonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C

Eric O Long, J. Shabanowitz, D. Hunt, 2016, bioRxiv.

Inhibitory receptor gp49B regulates eosinophil infiltration during allergic inflammation

A. Keane-Myers, J. Urban, R. M. Anthony, 2007, Journal of leukocyte biology.

This information is current as Interact Productively with DM Complexes Does Not Reflect a Failure to II Molecule to Form Stable Peptide The Inability of the Nonobese Diabetic Class

A. Sant, M. Peterson, 2017 .

Invariant chain influences the immunological recognition of MHC class II molecules

Jim Miller, M. Peterson, 1990, Nature.

Cutting Edge: NK Cell Licensing Modulates Adhesion to Target Cells

Eric O Long, M. Peterson, L. Thomas, 2013, The Journal of Immunology.

This information is current as Adhesion To Target Cells Cutting Edge : NK Cell Licensing Modulates

M. Peterson, E. O. Long, L. Thomas, 2013 .

Broadly neutralizing antibodies target the coronavirus fusion peptide

Peter D. Crompton, J. Mascola, J. Yewdell, 2022, Science.

DependentAlternate Conformations That Are Peptide Exists in g7 The MHC Class II Molecule I-A

M. Peterson, L. Arneson, 2000 .

Atypical B cells up-regulate costimulatory molecules during malaria and secrete antibodies with T follicular helper cell support

Peter D. Crompton, J. Skinner, S. Anzick, 2022, Science Immunology.

In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM.

R. Lechler, G. Lombardi, R. Hargreaves, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses

Peter D. Crompton, J. Mascola, J. Yewdell, 2022, Cell Host & Microbe.

Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern

Peter D. Crompton, J. Mascola, I. Wilson, 2021, Science Translational Medicine.

NK cell defects in X-linked pigmentary reticulate disorder

N. Grishin, A. Zinn, L. Kinch, 2019, JCI insight.

Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali.

Peter D. Crompton, Zonghui Hu, A. McDermott, 2022, The New England journal of medicine.

Controlling natural killer cell responses: integration of signals for activation and inhibition.

Sumati Rajagopalan, Eric O Long, S. Rajagopalan, 2013, Annual review of immunology.

Plasmodium falciparum–specific IgM B cells dominate in children, expand with malaria, and produce functional IgM

Peter D. Crompton, Eric O Long, R. Koup, 2021, The Journal of experimental medicine.

Atypical B cells upregulate co-stimulatory molecules during malaria and secrete antibodies with T follicular helper cell support

Peter D. Crompton, J. Skinner, S. Anzick, 2021, bioRxiv.

Inhibition of natural killer cell activation signals by killer cell immunoglobulin‐like receptors (CD158)

D. F. Barber, Eric O Long, M. Sandusky, 2001, Immunological reviews.

KIR enrichment at the effector‐target cell interface is more sensitive than signaling to the strength of ligand binding

Eric O Long, M. Sandusky, D. Burshtyn, 2003, European journal of immunology.

Trans-endocytosis of intact IL-15Rα–IL-15 complex from presenting cells into NK cells favors signaling for proliferation

Eric O Long, T. Waldmann, K. Garcia, 2019, Proceedings of the National Academy of Sciences.

Functional human IgA targets a conserved site on malaria sporozoites

Peter D. Crompton, I. Wilson, P. Sinnis, 2021, Science Translational Medicine.